Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis

Eran R. Andrechek, William R. Hardy, Peter M. Siegel, Michael A. Rudnicki, Robert Cardiff, William J. Muller

Research output: Contribution to journalArticle

164 Citations (Scopus)

Abstract

The neu (c-erbB-2, Her-2) protooncogene is amplified and overexpressed in 20-30% of human breast cancers. Although transgenic mouse models have illustrated the role of Neu in the induction of mammary tumors, Neu expression in these models is driven by a strong viral promoter of questionable relevance to the human disease. To ascertain whether expression of activated Neu under the control of the endogenous promoter in the mammary gland could induce mammary tumors we have generated mice that conditionally express activated Neu under the transcriptional control of the intact endogenous Neu promoter. Expression of oncogenic neu in the mammary gland resulted in accelerated lobuloalveolar development and formation of focal mammary tumors after a long latency period. However, expression of activated Neu under the normal transcriptional control of the endogenous promoter was not sufficient for the initiation of mammary carcinogenesis. Strikingly, all mammary tumors bear amplified copies (2-22 copies) of the activated neu allele relative to the wild-type allele and express highly elevated levels of neu transcript and protein. Thus, like human erbB-2-positive breast tumors, mammary tumorigenesis in this mouse model requires the amplification and commensurate elevated expression of the neu gene.

Original languageEnglish (US)
Pages (from-to)3444-3449
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume97
Issue number7
DOIs
StatePublished - Mar 28 2000

Fingerprint

Oncogenes
Carcinogenesis
Breast
Breast Neoplasms
Human Mammary Glands
Alleles
erbB-2 Genes
Transgenic Mice
Proteins

ASJC Scopus subject areas

  • General

Cite this

Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. / Andrechek, Eran R.; Hardy, William R.; Siegel, Peter M.; Rudnicki, Michael A.; Cardiff, Robert; Muller, William J.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, No. 7, 28.03.2000, p. 3444-3449.

Research output: Contribution to journalArticle

Andrechek, Eran R. ; Hardy, William R. ; Siegel, Peter M. ; Rudnicki, Michael A. ; Cardiff, Robert ; Muller, William J. / Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. In: Proceedings of the National Academy of Sciences of the United States of America. 2000 ; Vol. 97, No. 7. pp. 3444-3449.
@article{25471bef498c49acba118f4b3037c6af,
title = "Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis",
abstract = "The neu (c-erbB-2, Her-2) protooncogene is amplified and overexpressed in 20-30{\%} of human breast cancers. Although transgenic mouse models have illustrated the role of Neu in the induction of mammary tumors, Neu expression in these models is driven by a strong viral promoter of questionable relevance to the human disease. To ascertain whether expression of activated Neu under the control of the endogenous promoter in the mammary gland could induce mammary tumors we have generated mice that conditionally express activated Neu under the transcriptional control of the intact endogenous Neu promoter. Expression of oncogenic neu in the mammary gland resulted in accelerated lobuloalveolar development and formation of focal mammary tumors after a long latency period. However, expression of activated Neu under the normal transcriptional control of the endogenous promoter was not sufficient for the initiation of mammary carcinogenesis. Strikingly, all mammary tumors bear amplified copies (2-22 copies) of the activated neu allele relative to the wild-type allele and express highly elevated levels of neu transcript and protein. Thus, like human erbB-2-positive breast tumors, mammary tumorigenesis in this mouse model requires the amplification and commensurate elevated expression of the neu gene.",
author = "Andrechek, {Eran R.} and Hardy, {William R.} and Siegel, {Peter M.} and Rudnicki, {Michael A.} and Robert Cardiff and Muller, {William J.}",
year = "2000",
month = "3",
day = "28",
doi = "10.1073/pnas.97.7.3444",
language = "English (US)",
volume = "97",
pages = "3444--3449",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "7",

}

TY - JOUR

T1 - Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis

AU - Andrechek, Eran R.

AU - Hardy, William R.

AU - Siegel, Peter M.

AU - Rudnicki, Michael A.

AU - Cardiff, Robert

AU - Muller, William J.

PY - 2000/3/28

Y1 - 2000/3/28

N2 - The neu (c-erbB-2, Her-2) protooncogene is amplified and overexpressed in 20-30% of human breast cancers. Although transgenic mouse models have illustrated the role of Neu in the induction of mammary tumors, Neu expression in these models is driven by a strong viral promoter of questionable relevance to the human disease. To ascertain whether expression of activated Neu under the control of the endogenous promoter in the mammary gland could induce mammary tumors we have generated mice that conditionally express activated Neu under the transcriptional control of the intact endogenous Neu promoter. Expression of oncogenic neu in the mammary gland resulted in accelerated lobuloalveolar development and formation of focal mammary tumors after a long latency period. However, expression of activated Neu under the normal transcriptional control of the endogenous promoter was not sufficient for the initiation of mammary carcinogenesis. Strikingly, all mammary tumors bear amplified copies (2-22 copies) of the activated neu allele relative to the wild-type allele and express highly elevated levels of neu transcript and protein. Thus, like human erbB-2-positive breast tumors, mammary tumorigenesis in this mouse model requires the amplification and commensurate elevated expression of the neu gene.

AB - The neu (c-erbB-2, Her-2) protooncogene is amplified and overexpressed in 20-30% of human breast cancers. Although transgenic mouse models have illustrated the role of Neu in the induction of mammary tumors, Neu expression in these models is driven by a strong viral promoter of questionable relevance to the human disease. To ascertain whether expression of activated Neu under the control of the endogenous promoter in the mammary gland could induce mammary tumors we have generated mice that conditionally express activated Neu under the transcriptional control of the intact endogenous Neu promoter. Expression of oncogenic neu in the mammary gland resulted in accelerated lobuloalveolar development and formation of focal mammary tumors after a long latency period. However, expression of activated Neu under the normal transcriptional control of the endogenous promoter was not sufficient for the initiation of mammary carcinogenesis. Strikingly, all mammary tumors bear amplified copies (2-22 copies) of the activated neu allele relative to the wild-type allele and express highly elevated levels of neu transcript and protein. Thus, like human erbB-2-positive breast tumors, mammary tumorigenesis in this mouse model requires the amplification and commensurate elevated expression of the neu gene.

UR - http://www.scopus.com/inward/record.url?scp=0034724314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034724314&partnerID=8YFLogxK

U2 - 10.1073/pnas.97.7.3444

DO - 10.1073/pnas.97.7.3444

M3 - Article

C2 - 10716706

AN - SCOPUS:0034724314

VL - 97

SP - 3444

EP - 3449

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 7

ER -